search
  • Home
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • News
    • Events
    • Careers
  • Research & Pipeline
    • Paxalisib
    • Cantrixil
    • Collaborations
    • Publications & Presentations
  • Partnering
  • Investor Centre
    • ASX Announcements
    • SEC Filings
    • Company Reports
    • Company Meetings
    • Corporate Presentations
    • Analyst Reports
    • Investor Newsletters
    • Shareholder Services
    • COVID-19
    • Entitlement Offer
  • Media Centre
    • Video
    • Insights
MENU
  • Home
  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • News
    • Events
    • Careers
  • Research & Pipeline
    • Overview
    • Paxalisib
    • Cantrixil
    • Test
    • Collaborations
    • Publications & Presentations
  • Partnering
  • Investor Centre
    • Overview
    • ASX Announcements
    • SEC Filings
    • Company Reports
    • Company Meetings
    • Corporate Presentations
    • Analyst Reports
    • Investor Newsletters
    • Shareholder Services
    • COVID-19
    • Entitlement Offer
  • Media Centre
    • Video
    • Insights
  • CONTACT US
  • /
  • Media Centre
  • /
  • Video
  • Media Centre
  • Overview
  • Video
  • Insights

  • 19-Apr-2017

    Briefing on ATM program by our CEO, Dr James Garner to the Hon Paul Fletcher MP, Minister for Bradfield

  • 12-Apr-2017

    Shareholder Information Session Recording

  • 16-Mar-2017

    Swings and Roundabouts radio interview about our new development program for brain cancer, GDC-0084

  • 2-Nov-2016

    Dr James Garner discusses in-licencing of GDC-0084 with FNN

  • 31-Oct-2016

    Sky News Interview – In-licensing of GDC-0084
    • 1
    • 2
  • SITE MAP
  • /
  • PRINT PAGE
  • /
  • TERMS OF USE
  • /
  • PRIVACY

  • FORWARD-LOOKING STATEMENTS
  • /
  • COOKIE POLICY
SITE BY SPATIAL DESIGN